Rani Therapeutics Holdings, Inc. (RANI)
USD 1.12
(2.83%)
USD 1.12
(2.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -51.23 Million | -46.51 Million | -32.24 Million | -14.96 Million | -26.26 Million |
| Net Income | -33.97 Million | -63.34 Million | -53.08 Million | -16.7 Million | -26.58 Million |
| Depreciation & Amortization | 822 Thousand | 548 Thousand | 497 Thousand | 589 Thousand | 564 Thousand |
| Deferred income taxes | -21.24 Million | - | 1.07 Million | - | - |
| Stock-based compensation | 19 Million | 15.78 Million | 22.59 Million | - | - |
| Change in working capital | -2.14 Million | 509 Thousand | -3.42 Million | 1.04 Million | -163 Thousand |
| Other non-cash items | -13.7 Million | -10 Thousand | 109 Thousand | 110 Thousand | -81 Thousand |
| Investing Cash Flow | 29.86 Million | -72.43 Million | -506 Thousand | -1.2 Million | -1.53 Million |
| Investments in PPE | -1.22 Million | -1.61 Million | -506 Thousand | -1.2 Million | -1.58 Million |
| Acquisitions | -2.31 Million | -851 Thousand | - | - | 49 Thousand |
| Investment purchases | -73.26 Million | -73.81 Million | - | - | - |
| Sales/Maturities of investments | 104.35 Million | 3 Million | - | - | - |
| Other Investing Activities | 2.31 Million | 851 Thousand | - | - | 49.00 |
| Financing Cash Flow | 233.00 | 29 Million | 77.14 Million | 72.68 Million | 852 Thousand |
| Debt repayment | - | -29.31 Million | -4.56 Million | -1.41 Million | -852 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -162.00 | -626.00 | - | - | - |
| Common Stock Issuance | 395 Thousand | 317 Thousand | 73.64 Million | 71.27 Million | - |
| Other Financing Activities | 395.00 | -626 Thousand | 8.06 Million | 2.82 Million | 852 Thousand |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | -595 Thousand | 163 Thousand | 543 Thousand | 933 Thousand | -271 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | -1.54 Million | 346 Thousand | -3.97 Million | 111 Thousand | 108 Thousand |
| Cash at beginning of period | 27.5 Million | 117.45 Million | 73.05 Million | 16.53 Million | 43.48 Million |
| Cash at end of period | 6.36 Million | 27.5 Million | 117.45 Million | 73.05 Million | 16.53 Million |
| Capital Expenditure | -1.22 Million | -1.61 Million | -506 Thousand | -1.2 Million | -1.58 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -21.14 Million | -89.94 Million | 44.39 Million | 56.52 Million | -26.94 Million |
| Free Cash Flow | -52.46 Million | -48.13 Million | -32.75 Million | -16.16 Million | -27.84 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.8 Million | -7.48 Million | -33.97 Million | -7.09 Million | -18.33 Million | -18.66 Million |
| Depreciation & Amortization | 255 Thousand | 248 Thousand | 822 Thousand | 227 Thousand | 218 Thousand | 189 Thousand |
| Deferred income taxes | - | - | -21.24 Million | -5.6 Million | -609 Thousand | -543 Thousand |
| Stock-based compensation | 4.12 Million | 3.87 Million | 19 Million | 4.48 Million | 4.96 Million | 5.14 Million |
| Change in working capital | 81 Thousand | 1.16 Million | -2.14 Million | -2.99 Million | -864 Thousand | 1.25 Million |
| Other non-cash items | -1.75 Million | -2.99 Million | -13.7 Million | -1.5 Million | 318 Thousand | 318 Thousand |
| Investing Cash Flow | 6.52 Million | 10.29 Million | 29.86 Million | 13.27 Million | 11.67 Million | 789 Thousand |
| Investments in PPE | -94 Thousand | -18 Thousand | -1.22 Million | -167 Thousand | -479 Thousand | -335 Thousand |
| Acquisitions | - | - | -2.31 Million | -13.44 Thousand | -12.15 Thousand | -1124.00 |
| Investment purchases | -11.58 Million | -10.03 Million | -73.26 Million | -9.4 Million | -11.34 Million | -33.87 Million |
| Sales/Maturities of investments | 18.2 Million | 20.35 Million | 104.35 Million | 22.85 Million | 23.5 Million | 35 Million |
| Other Investing Activities | 6.61 Million | 340 Thousand | 2.31 Million | 13.44 Thousand | 12.15 Thousand | 1124.00 |
| Financing Cash Flow | 141 Thousand | 121 Thousand | 233.00 | 96.00 | 49.00 | 80.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -24 Thousand | - | -162.00 | 355.16 Thousand | -29.00 | -9.00 |
| Common Stock Issuance | 165 Thousand | 121 Thousand | 395 Thousand | 96 Thousand | 78 Thousand | 89 Thousand |
| Other Financing Activities | -24 Thousand | 121 Thousand | 395.00 | 96.00 | 78.00 | 89.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -300 Thousand | 158 Thousand | -595 Thousand | -663 Thousand | 400 Thousand | -408 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 381 Thousand | 1 Million | -1.54 Million | -2.32 Million | -1.26 Million | 1.66 Million |
| Cash at beginning of period | 7.37 Million | 6.36 Million | 27.5 Million | 5.47 Million | 8.05 Million | 19.48 Million |
| Cash at end of period | 5.01 Million | 7.37 Million | 6.36 Million | 6.36 Million | 5.47 Million | 8.05 Million |
| Capital Expenditure | -94 Thousand | -18 Thousand | -1.22 Million | -167 Thousand | -479 Thousand | -335 Thousand |
| Effect of forex changes on cash | - | - | - | -28.09 Million | 9.04 Million | 19.04 Million |
| Net cash flow / Change in cash | -2.36 Million | 1.01 Million | -21.14 Million | 892 Thousand | -2.58 Million | -11.43 Million |
| Free Cash Flow | -9.12 Million | -9.42 Million | -52.46 Million | -12.64 Million | -14.78 Million | -12.63 Million |
OBDE
0064
JNNDF
PYTCF
600681
ALY